Company intelligence / Profile preview

Capillus

Doral/Miami area, Florida, United Statescapillus.com ↗

Ownership: Private
Development stage: Commercial

Overview

Capillus offers FDA-cleared low-level laser therapy devices for home and clinical use targeting androgenetic alopecia. Clinical studies suggest efficacy in reducing hair thinning and promoting regrowth, though reviews are mixed. Devices are also marketed for pain relief, skin rejuvenation, and cognitive wellness.

Therapeutic areas: DermatologyRheumatology
Modalities: DeviceNon-pharmacological therapy (Low-level laser therapy / red light therapy)
Industry: Therapeutic Medical Devices

Partnerships

Extensive network of hair restoration physicians; no major pharma or biotech partnerships disclosed.

Beyond the preview

Go deeper on Capillus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capillus.

Explore the full profile